Table1.
Phenotypic and Genotypic Prevalence of MBL Types in Different Cities of Iran
| MBL Type | Percentage (%) | City | Total Isolates | MR (%) | Resistance | Year | Reference |
|---|---|---|---|---|---|---|---|
| VIM | 6.34 19.51 17.30 12.36 2.62 13a 16.1 2.1a 32.85 5.17 7.5a 21.3, 24a 0.46 |
Tehran Ahvaz Tabriz Tehran Tehran Tehran Tehran Tehran Zanjan Urmia Shiraz Arak Kermanshah |
126 100B 104 186B 610 100B 483 483 70 58 240B 108 225 |
- - - 82.6 - - - - - - - - - |
Imipenem Imipenem Imipenem Imipenem Imipenem Imipenem Imipenem imipenem Imipenem Imipenem Imipenem Imipenem Imipenem, meropenem |
2007 2008 2010 2010 2010 2010 2012 2012 2013 2013 2012 2014 2015 |
(27) (19) (24) (22) (28) (21) (29) (29) (30) (31) (32) (33) (34) |
| IMP | 5.76 57.9 6.6 3.3b 14.28 3.41 7.5b 1.3 15.11 |
Tabriz Tehran Tehran Tehran Zanjan Urmia Shiraz Tehran Kermanshah |
104 100 483 483 70 58 240 75 225B |
- 8.3 - - - - - - - |
Imipenem Imipenem Imipenem Imipenem Imipenem Imipenem Imipenem Imipenem Imipenem, meropenem |
2010 2013 2012 2012 2013 2013 2012 2012 2015 |
(26) (30) (35) (34) |
MBL, metallo-beta-lactamase;
a
VIM-2;
b
IMP-2;
B
isolates from burn injuries; MR, mortality rate